Skip to main content

Table 1 Patients' Demographics.

From: Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial

  TA (n = 19) Placebo (n = 19) P-Value
Age (y) 55 ± 11 60 ± 7 0.17
M/F 18/1 18/1 1.0
Wt. (Kg) 73 ± 15 71 ± 14 0.74
BMI 27 ± 4 27 ± 4 1.0
Smoking 6 (31.5%) 6 (31.5%) 1.0
Diabetes 7 (37%) 10 (53%) 0.42
Hypertension 7 (37%) 12 (63%) 0.17
Hyperchol 3 (16%) 0 (0%) 0.08
COPD 1 (5%) 1 (5%) 1.0
RF 0 (0%) 1 (5%) 0.33
PVD 3 (16%) 0 (0%) 0.08
Previous MI 4 (21%) 6 (31.5%) 0.42
LVEF 48 ± 10 46 ± 10 0.49
Euroscore 2.3 ± 1.7 2.5 ± 1.6 0.58
  1. Values are means ± SD or No.(%) where shown.
  2. M/F: Male/Female
  3. Wt.: Weight
  4. BMI: Body Mass Index
  5. COPD: Chronic Obstructive Pulmonary Disease
  6. RF: Renal Failure
  7. Hyperchol: Hypercholesterolmia
  8. PVD: Peripheral Vascular Disease
  9. MI: Myocardial Infarction
  10. LVEF: Left Ventricular Ejection Fraction